DXCM logo

DXCM
Dexcom Inc

10,026
Mkt Cap
$23.57B
Volume
1.95M
52W High
$89.98
52W Low
$54.11
PE Ratio
29.26
DXCM Fundamentals
Price
$63.09
Prev Close
$61.23
Open
$62.28
50D MA
$67.65
Beta
0.81
Avg. Volume
4.1M
EPS (Annual)
$2.09
P/B
8.58
Rev/Employee
$420,000.00
$26,304.04
Loading...
Loading...
News
all
press releases
Michael Jon Brown Sells 1,700 Shares of DexCom (NASDAQ:DXCM) Stock
DexCom, Inc. (NASDAQ:DXCM - Get Free Report) EVP Michael Jon Brown sold 1,700 shares of DexCom stock in a transaction dated Wednesday, April 15th. The stock was sold at an average price of $63.04...
MarketBeat·16h ago
News Placeholder
More News
News Placeholder
Here's Why You Should Add DexCom Stock to Your Portfolio Now
DexCom's expanding CGM market, G7 rollout, and global growth momentum position it for gains, despite pricing pressure and near-term margin risks.
Zacks·1d ago
News Placeholder
DexCom, Inc. $DXCM Shares Sold by Robeco Institutional Asset Management B.V.
Robeco Institutional Asset Management B.V. lowered its stake in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 45.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 104,172 shares of the medi...
MarketBeat·1d ago
News Placeholder
DexCom (DXCM) Upgraded to Buy: Here's Why
DexCom (DXCM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks·2d ago
News Placeholder
Sumitomo Mitsui Trust Group Inc. Sells 15,977 Shares of DexCom, Inc. $DXCM
Sumitomo Mitsui Trust Group Inc. lowered its stake in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 1.6% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange...
MarketBeat·2d ago
News Placeholder
DexCom, Inc. $DXCM Shares Sold by Massachusetts Financial Services Co. MA
Massachusetts Financial Services Co. MA decreased its holdings in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 85.9% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 793,427 shares of the medical device company's stock after selli...
MarketBeat·2d ago
News Placeholder
Here's Why DexCom (DXCM) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks·3d ago
News Placeholder
Baillie Gifford & Co. Decreases Stake in DexCom, Inc. $DXCM
Baillie Gifford & Co. decreased its position in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 2.1% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund...
MarketBeat·4d ago
News Placeholder
Greenup Street Wealth Management LLC Makes New Investment in DexCom, Inc. $DXCM
Greenup Street Wealth Management LLC bought a new position in DexCom, Inc. (NASDAQ:DXCM - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The...
MarketBeat·5d ago
News Placeholder
Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, April 9, 2026 Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We...
PR Newswire·8d ago
<
1
2
...
>

Latest DXCM News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.